Medunik USA is dedicated to providing Americans suffering from rare diseases with access to orphan drugs that are not currently available in the U.S. We make these treatment options available by building strategic partnerships with international companies to bring their products to the American market.
Through in-licensing partnerships, Medunik USA offers turn-key operations and provides medical scientific liaisons, approval and market access processes and marketing for orphan disease treatments.
Medunik USA is part of the Duchesnay group, which consists of five pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad.
In 2009, the company launched Medunik Canada to bring orphan drugs to Canadians with rare diseases.
Today, Medunik USA brings orphan drugs to the U.S. market to provide Americans with rare diseases with the life-changing and potentially life-saving treatment options they deserve.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 919 Conestoga Road, Building One
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- medunikusa.com
- HQ
- Rosemont, PA
Medunik Usa Questions
Medunik Usa's website is medunikusa.com
Medunik Usa's LinkedIn profile is https://www.linkedin.com/company/medunik-usa
Medunik Usa has
5 employees.
View email and phone details for 5
employees at Medunik Usa.
Medunik Usa's industry is
Pharmaceutical Manufacturing
Medunik Usa's top competitors are
Azurity Pharmaceuticals,
Duchesnay,
Ionis Pharmaceuticals, Inc.,
Groupe Pharmaceutique Duchesnay,
Duchesnay Pharmaceutical Group,
Analog Pharma,
Medly,
Duchesnay Usa,
Eton Pharmaceuticals,
Medunik Canada.
Medunik Usa's categories are Pharmaceutical Manufacturing
Medunik Usa's founding year is 2016
